EPISODE · Aug 27, 2025 · 3 MIN
Gideon Korrell Talks About Paliperidone Palmitate Patent Ruling
from Gideon Korrell · host Gideon Korrell
In this episode, Gideon Korrell breaks down the Federal Circuit’s ruling in Janssen v. Teva, where the court upheld Janssen’s patent on paliperidone palmitate’s unique dosing regimen. He explains why the case matters for pharmaceutical patents, Hatch-Waxman disputes, and the limits of obviousness in drug development.
What this episode covers
In this episode, Gideon Korrell breaks down the Federal Circuit’s ruling in Janssen v. Teva, where the court upheld Janssen’s patent on paliperidone palmitate’s unique dosing regimen. He explains why the case matters for pharmaceutical patents, Hatch-Waxman disputes, and the limits of obviousness in drug development.
NOW PLAYING
Gideon Korrell Talks About Paliperidone Palmitate Patent Ruling
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.